Journal: Digestive Surgery
Submission Deadline: November 30, 2024
Digestive Surgery is calling for submissions to the article collection "Rare Cancers of the Gastrointestinal Tract and Peritoneum”.
Rare cancers of the gastrointestinal tract and peritoneum, such as gastrointestinal stromal tumors (GIST), mesothelioma, and pseudomyxoma peritonei, present distinct diagnostic and therapeutic challenges. Additionally, the landscape of treatment for peritoneal carcinomatosis is constantly evolving, with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) and other modalities offering promising improvements in patient outcomes.
Our goal is to gather high-quality original research, reviews, and systematic reviews that elucidate the pathophysiology, diagnosis, and innovative treatment approaches for these rare cancers. We aim to foster collaboration and knowledge-sharing among researchers, clinicians, and other healthcare professionals.
We welcome articles that cover a wide range of topics, including molecular biology, clinical trials, patient management strategies, and emerging therapies. Contributions that provide new insights into epidemiology, early detection, and personalized medicine are highly encouraged.
Please select the option “Call for Papers: Rare Gastrointestinal and Peritoneal Cancers” when submitting your manuscript and mention this Call for Papers in your cover letter.
Digestive Surgery supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.
Check out the Author Guidelines.